European Union - English - EMA (European Medicines Agency)

orion corporation - levodopa, carbidopa, entacapone - parkinson disease - nervous system - levodopa/carbidopa/entacapone orion is indicated for the treatment of adult patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa / dopa-decarboxylase (ddc)-inhibitor treatment.

European Union - English - EMA (European Medicines Agency)

orion corporation - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in adult patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

orion pharma (my) sdn. bhd. - hydrocortisone -

Ireland - English - HPRA (Health Products Regulatory Authority)

orion corporation - carbidopa monohydrate; levodopa - tablet - levodopa and decarboxylase inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

orion corporation - carbidopa monohydrate; levodopa - tablet - levodopa and decarboxylase inhibitor

Canada - English - Health Canada

fresenius kabi canada ltd - chorionic gonadotropin - powder for solution - 10000unit - chorionic gonadotropin 10000unit - gonadotropins and antigonadotropins

Ireland - English - HPRA (Health Products Regulatory Authority)

orion corporation - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

Ireland - English - HPRA (Health Products Regulatory Authority)

orion corporation - methotrexate - tablet - 10 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

European Union - English - EMA (European Medicines Agency)

orion corporation - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.

European Union - English - EMA (European Medicines Agency)

orion corporation - toremifene - breast neoplasms - endocrine therapy - first line hormone treatment of hormone-dependent metastatic breast cancer in postmenopausal patients.fareston is not recommended for patients with estrogen receptor negative tumours.